Bhavesh Mohan Lal, MD, UAMS College of Medicine, Little Rock, Arkansas, reviews a study designed to investigate the effects of prior exposure to BCMA-targeting agents on outcomes with…
Praneeth Reddy Sudalagunta, PhD, applied research scientist, Moffitt Cancer Center, Tampa, Florida, discusses the differential effects of bridging therapy on the immune microenvironment as well as outcomes with…
NEW YORK (Reuters Health) – New research suggests that high-dose vitamin D can be safely given to breast cancer patients with bone metastases, but it will not affect…
Robert Shorr, Ph.D, D.I.C, CEO, Cornerstone Pharmaceuticals, discusses how physicians can understand a new oncology drug, starting with knowing its safety limitations. He also explains the structure and…
NEW YORK (Reuters Health) – Contrary to previous assertions, low total cholesterol is not a cause of cancer, two separate studies show. Furthermore, a lower total cholesterol level…
NEW YORK (Reuters Health) – Neoadjuvant treatment with erlotinib (Tarceva), an epidermal growth factor receptor (EGFR) inhibitor, can help downstage bladder cancer to organ-confined disease, thereby increasing the…
NEW YORK (Reuters Health) – In detecting prostate cancer, no single prostate specific antigen (PSA) cut-off value achieves the likelihood ratios usually required of a screening test, according…
Jay Alberts, PhD, Assistant Staff, Lerner Research Institute, Cleveland Clinic, gives us an overview of Parkinson’s Disease and describes study results which showed that exercise therapy had a…
NEW YORK (Reuters Health) – Liver transplant recipients whose indication for transplant was hepatitis C virus (HCV) cirrhosis have markedly poorer survival compared to patients transplanted for alcoholic…
NEW YORK (Reuters Health) Extended-duration treatment with the neuraminidase inhibitors (NAIs) oseltamivir or zanamivir can help prevent symptomatic influenza in immunocompetent adults, a review and analysis of trial…
NEW YORK (Reuters Health) – The results of a randomized trial indicate that sequential and alternating chemotherapy with radiotherapy provide similar survival and larynx preservation in patients with…
NEW YORK (Reuters Health) – Depression related to peginterferon therapy for chronic hepatitis C increases with duration of use, but reverses following treatment cessation, according to data from…
